Aquilo Capital Management
Project Details
Aquilo Capital invests in drug development companies that harness the power of cutting-edge science to address urgent medical needs. They employ deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. In their view, these investment opportunities offer both substantial risk-adjusted returns as well as paradigm-changing therapeutics for patients and for society. Marc Schneidman, Founder & CIO, has over 20 years of dedicated investing experience across the biotechnology universe.
Aquilo Capital wanted a fresh website design that incorporates dynamic information that pulls the user in, telling a fresh and engaging story. It’s intentionally user-friendly, striking a balance between simplicity and professionalism while keeping the content up-to-date. Including team headshots boosts the website’s attractiveness.
This newly designed, responsive website on Custom WordPress stands out from other websites due to its fresh design and advanced features, offering a unique user experience.